Sahloff, Eric G

Eric G Sahloff
Close

Positions

Associate Professor, Pharmacy Practice , College of Pharmacy and Pharmaceutical Sciences

Contact Info

eric.sahloff@utoledo.edu

selected publications

Article (Faculty180)
- 2022
  
  Is long-acting cabotegravir a pre-exposure prophylaxis option for women of child-bearing potential?. Open Forum Infectious Diseases.
- 2021
  
  Time between diagnosis and achievement of virologic suppression in people living with HIV. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
- 2014
  
  Doc, I Just Can’t Swallow Pills”: HIV Infected Patients and Pill Phagophobia.. Journal of AIDS & Clinical Research.
- 2013
  
  Gingival Hypertrophy Associated with Amlodipine Use in  an HIV-Infected Woman. J Pharm Technol . 29:175-177.
- 2010
  
  A standardized rubric to evaluate student presentations. American journal of pharmaceutical education. 74:171.
- 2010
  
  Evaluating the validity and reliability of a modified survey to assess patient satisfaction with mail-order and community pharmacy settings. Journal of pharmacy practice. 23:128-34.
- 2009
  
  Maraviroc: a coreceptor CCR5 antagonist for management of HIV infection. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 66:715-26.
- 2007
  
  Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir. The Annals of pharmacotherapy. 41:1306-9.
- 2005
  
  Current issues in the development of a vaccine to prevent human immunodeficiency virus: insights from the society of infectious diseases pharmacists. Pharmacotherapy. 25:741-7.
- 2002
  
  E-testing for the determination of MICs for selected fluoroquinolones against Pseudomonas aeruginosa and Streptococcus pneumoniae. . J Pharm Technol . 18:241-247.
- 2002
  
  Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections. Expert opinion on pharmacotherapy. 3:1251-66.
- 2002
  
  Extended-Spectrum -Lactamase Resistance in the ICU. J Pharm Practice . 15:96-105.
- 2001
  
  The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy. 47:581-7.
Article (Web of Science)
- 2021
  
  Use of an On-Site Outpatient Pharmacy for Acquisition of Antiretroviral Medications Compared to Off-Site Pharmacy Options: Impact on Retention in Care and Clinical Outcomes in People Living With HIV. JOURNAL OF PHARMACY PRACTICE. 34:224-229.
  Full Text via DOI: 10.1177/0897190019866324 PMID: 31370729
- 2019
  
  Clinical Outcomes Associated With Once-Daily Ritonavir-Boosted Darunavir Plus Tenofovir/Emtricitabine in HIV-Infected Patients Harboring at Minimum a M184V/I Resistance Mutation. ANNALS OF PHARMACOTHERAPY. 53:50-55.
  Full Text via DOI: 10.1177/1060028018790574
- 2016
  
  Evaluation of Serum Creatinine Changes With Integrase Inhibitor Use in Human Immunodeficiency Virus-1 Infected Adults. OPEN FORUM INFECTIOUS DISEASES. 3.
  Full Text via DOI: 10.1093/ofid/ofw053
- 2015
  
  Alternative antiretroviral therapy formulations for patients unable to swallow solid oral dosage forms. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 72:1555-1565.
  Full Text via DOI: 10.2146/ajhp140575
- 2010
  
  A Standardized Rubric to Evaluate Student Presentations. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION. 74.
- 2010
  
  A Standardized Rubric to Evaluate Student Presentations. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION. 74:171.
  Full Text via DOI: 10.5688/aj7409171
- 2007
  
  Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir. ANNALS OF PHARMACOTHERAPY. 41:1306-1309.
  Full Text via DOI: 10.1345/aph.1k075
- 2006
  
  Clinical outcomes associated with concomitant use of atazanavir and proton pump inhibitors. ANNALS OF PHARMACOTHERAPY. 40:1731-1736.
  Full Text via DOI: 10.1345/aph.1H217
- 2006
  
  Clinical Outcomes Associated with Concomitant Use of Atazanavir and Proton Pump Inhibitors. ANNALS OF PHARMACOTHERAPY. 40:1731-1736.
  Full Text via DOI: 10.1345/aph.1h217
- 2001
  
  The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy. 47:581-587.
  Full Text via DOI: 10.1093/jac/47.5.581
Presentation (Faculty180)
- 2020
  
  The effectiveness of a financial incentive program on chronic HIV disease management
Review Article (Web of Science)
- 2009
  
  Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 715-726.
  Full Text via DOI: 10.2146/ajhp080206
- 2005
  
  Current issues in the development of a vaccine to prevent human immunodeficiency virus - Insights from the society of infectious diseases pharmacists. PHARMACOTHERAPY. 741-747.
- 2005
  
  Use of highly active antiretroviral therapy in patients with renal insufficiency. PHARMACOTHERAPY. 698-708.
- 2005
  
  Current Issues in the Development of a Vaccine to Prevent Human Immunodeficiency Virus: Insights from the Society of Infectious Diseases Pharmacists. PHARMACOTHERAPY. 741-747.
  Full Text via DOI: 10.1592/phco.25.5.741.63589
- 2005
  
  Use of Highly Active Antiretroviral Therapy in Patients with Renal Insufficiency. PHARMACOTHERAPY. 698-708.
  Full Text via DOI: 10.1592/phco.25.5.698.63588

full name

Eric G Sahloff

visualizations

Cumulative publications in Scholars@UToledo

Co-author Network

research areas